Michael joined Nanosonics as CEO and President effective October 2013. He was a Non-executive Director of the Board from July 2012 to October 2013. Michael has more than 26 years of international commercial experience in the healthcare market, having held local, regional and global roles in medical device and pharmaceutical industries. Before joining Nanosonics he was Senior Vice President of Global Marketing for the major medical device company Cochlear Ltd, a position he held for more than 10 years.
Steven Farrugia BE, PhD
Chief Technology Officer
Steven joined Nanosonics as Senior Vice President, Design and Development, in September 2016 and was appointed to the role of CTO in February 2018. He has over 21 years’ experience leading the development of medical devices. Prior to Nanosonics, Steven held a range of senior executive roles with ResMed, including VP of Technology and VP of Product Development. He is an inventor of almost 300 granted and pending patents and is an Adjunct Professor of Engineering at The University of Sydney.
McGregor Grant BEc, CA, GAICD, FGIA, FCIS
Chief Financial Officer and Company Secretary
McGregor joined Nanosonics in April 2011. He is responsible for the overall financial management of the Company and also serves as the Company Secretary. McGregor has more than 23 years’ business experience in a number of senior roles in the medical device and healthcare industries located in Australia and the United States, and previously worked for Coopers & Lybrand (now PwC) in Australia and Europe.
Rod Lopez MBA, BEng (Hons), GAICD
Chief Operating Officer
Rod joined Nanosonics in April 2019. He is an international operations executive with over 20 years of experience, having held critical roles in companies such as Cochlear and GM Holden. During his 13-year tenure at Cochlear, Rod held roles such as Global Head of Manufacturing and Chair of the Operational Excellence Strategy Group. At GM Holden, Rod held senior management roles across operations and global customer support. Rod is also an award-winning academic with continuing Adjunct Faculty appointments for over 12 years with MGSM, AGSM and the University of Sydney Business School.
Jodi Sampson MBA(Exec), CPHR
Chief People and Culture Officer
Jodi joined Nanosonics in April 2020. Jodi is an experienced human resources professional who has contributed to strategy, culture and business transformation at an executive level in the finance, telco and IT industries. Most recently, Jodi was Head of Human Resources with the Eclipx Group. She has also led international human resource functions as HR Director for Samsung and Head of Human Resources, Asia Pacific at Orange Business Services.
Ronan Wright BSc, Bus Management, BEng
Regional President for Europe, Middle East and Africa
Ronan joined Nanosonics in September 2019 and is responsible for Nanosonics’ continued expansion across Europe and the Middle East. He has more than 20 years’ experience in infection prevention through senior sales, management and business development roles with Advanced Sterilization Products and Wassenburg Medical, a global leader in endoscope reprocessing. Most recently, Ronan was the Vice President of Global Sales and a Board member at Wassenburg Medical, where he had also served as Managing Director for Ireland and Director of Business Development for EMEA.
Ken Shaw BSc Finance
Regional President for the United States, Canada and Latin America
Ken joined Nanosonics in September 2017 as Regional President for the United States, Canada and Latin America. He has more than 20 years’ experience in the healthcare, medical devices and consumer products industries. Most recently Ken was the President for Amoena GmbH and prior to that he held general management roles at BSN Medical, Medicom, Energizer and Pfizer.
David Morris BBus, BAppSc, GAICD
Chief Strategy Officer and Regional President Asia Pacific
David joined Nanosonics in February 2019. David has more than 25 years of executive leadership, international business development, and strategy experience. David was Chief Executive Officer and Managing Director at the Monash IVF Group, and prior to that he was an Executive at Cochlear Limited, where he was the Chief Strategy Officer, and the President of Bone Anchored Solutions. Prior to joining Cochlear Limited, David worked at Accenture in their Strategy practice.
Équipe de direction internationale
Katsumi Maruyama LLB
President, Nanosonics Japan K.K.
Katsumi joined Nanosonics in April 2016 as the Acting Country Manager for Japan, playing a significant role in the establishment & growth of the Japanese business during this time. Nanosonics Japan K.K. was established in January 2019 and in September 2019, Katsumi was appointed President of Nanosonics Japan K.K. Katsumi has over 25 years experience in developing and managing businesses & investments between Australia and Japan within the lifesciences sector. He has served as a board member and held senior management roles in major international companies in both Australia and Japan.
Gareth Daly BBS
Key Accounts Manager EMEA
Gareth joined Nanosonics in February 2020 to support existing business across Europe, Middle East and Africa. Gareth brings with him a wealth of specialist experience in the area of decontamination for reusable invasive medical devices. Gareth started his career with Wassenburg Medical Ireland, experts in endoscope reprocessing and infection prevention solutions before joining Cantel Medical Canada. Whilst supporting their North American expansion, he worked with procedural & infection prevention products for endoscopy and sterility products for Central Sterile Services Departments.
Henrik Wahlberg, MBA
Business Manager - Nordics & Baltics
Henrik joined Nanosonics in March, 2020 with 17 years worth of international healthcare experience, most recently from Ecolab where managed the Nordic infection prevention business. Before Ecolab, Henrik worked at Baxter Healthcare and Eli Lilly & Co. Henrik holds an undergraduate degree in finance from Indiana University as well as an MBA in General Management from INSEAD. He also holds LIF- (authorized medical sales license) and IMA- (authorized medical marketing license) certificates from the Swedish Pharmaceutical Industry Association.
Head of Business Development & Sales Lead D-A-CH
Ms. Klatt joined the Nanosonics team in October 2021. She has more than 20 years of national and international commercial experience in the healthcare market, having held local, regional and global roles in medical device industry. Before joining Nanosonics, she was working in several leadership and board roles in sales and marketing for companies like Medtronic, Hill-Rom, Baxter and Spacelabs. In addition, Ms. Klatt has been developing prospective executives in the context of training and coaching for many years. For her second degree in Marketing she was honored with the “German Study Award 2010”.